Recent Finacing
Recent Raise
Igyxos develops a monoclonal antibody that potentiates endogenous and exogenous gonadotropins to enhance therapeutic management of male and female infertility.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Igyxos.
